By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Immunology have been published. According to news reporting originating from Pittsburgh, Pennsylvania, by NewsRx correspondents, research stated, "To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT). Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT."
Our news editors obtained a quote from the research from the University of Pittsburgh School of Medicine, "After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45(+) leukocytes and subsets (T cells, myeloid cells, macrophages, neutrophils). Generalised estimation equations were used to compare cell counts between groups. PSS-AuNRs and Ab-AuNRs were visualised in the vitreous 30 min and 24 h post-injection with OCT. At 24 h, a statistically significant increase in leukocytes, comprised primarily of neutrophils, was observed in eyes that received either AuNR in comparison to eyes that received saline. The accumulation of leukocytes was equal in eyes given PSS-AuNR or Ab-AuNR. Endotoxin-resistant C3H/HeJ mice also showed ocular inflammation after injection with AuNRs, indicating that the inflammatory response was not due to lipopolysaccharide contamination of AuNRs."
According to the news editors, the research concluded: "Although AuNRs can be visualised in the eye using OCT, they can induce ocular inflammation, which limits their use as a contrast agent."
For more information on this research see: Inflammatory response to intravitreal injection of gold nanorods. The British Journal of Ophthalmology, 2012;96(12):1522-9 (see also Immunology).
The news editors report that additional information may be obtained by contacting M. Gabriele Sandrian, Dept. of Ophthalmology, UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, United States. Additional authors for this research include G. Wollstein, J.S. Schuman, R.A. Bilonick, Y. Ling, H. Ishikawa, L. Kagemann and K.C McKenna.
Keywords for this news article include: Pittsburgh, Immunology, Leukocytes, Phagocytes, Blood Cells, Neutrophils, Pennsylvania, Granulocytes, United States, Hemic and Immune Systems, North and Central America.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC